NCT03850795 2024-08-19
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Hinova Pharmaceuticals USA, Inc.
Phase 3 Terminated
Clinical Trials
4 trialsNCT04844749 2024-02-05
VERACITY
Veru Inc.
Phase 3 Terminated
NCT04409288 2024-01-05
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer
Chinese University of Hong Kong
Phase 3 Terminated
NCT02438007 2023-03-15
ARMOR3-SV
LTN PHARMACEUTICALS, INC.
Phase 3 Terminated